Management of Arterial Hypertension with Angiotensin Receptor Blockers: Current Evidence and the Role of Olmesartan

Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials (RCTs).

Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study.

A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily (BID) PPIs versus Once Daily (QD) for Treatment of Gastroesophageal Reflux Disease (GERD).

An Open Label, 2 Year Long Term Follow-Up Study to Assess the Efficacy, Safety and Tolerability of Teneligliptin in Indian Subjects with Type 2 Diabetes Mellitus.

Teneligliptin is non-inferior to sitagliptin for type 2 diabetes (T2DM) inadequately controlled with metformin and glimepiride

The Glycemic Pentad: A Key Element in Management of Type 2 Diabetes

Potential of angiotensin II receptor blockers (ARBs) in the treatment of diabetic retinopathy

Safety and Efficacy of long-term treatment with teneligliptin: Analysis of a postmarketing surveillance (PMS) of more than 10,000 Asian patients with type 2 diabetes mellitus (T2DM